Forefront Analytics, LLC
- SEC CIK
- 0001696802
- Latest filing
- Aug 12, 2026
Holdings changes from Q1 2026 to Q2 2026
Long positions only; new, added, reduced and sold out are based on share counts. Pick any two quarters this institution filed.
- New
- 0
- Added
- 19
- Est. +$1.91M
- Reduced
- 15
- Est. −$34.0M
- Sold out
- 2
- Est. −$264.4K
Portfolio value went from $110.0M to $92.0M (−$17.9M (−16.3%)); positions from 39 to 37 (−2).
All Q2 2026 holdingsAll Q1 2026 holdings
In the shares, value and % of portfolio columns, the top figure is Q2 2026 and the gray one below is Q1 2026. For stocks that split between the two quarters, Q1 2026 shares are converted at the split ratio before comparing.
| Security | Action | Shares | Share change | Value | Est. bought or sold | % of portfolio | Weight change (pp) |
|---|---|---|---|---|---|---|---|
| NKTXNkarta, Inc. | ReducedHistory | 28,95543,835 | −14,880−33.9% | $81.9K$92.5K | −$42.1K | 0.1%0.1% | 0.00 |
| Vanguard Morningstar Value ETF922908744 | Reduced– | 1,0841,317 | −233−17.7% | $236.3K$258.5K | −$50.8K | 0.3%0.2% | +0.02 |
| Schwab US Dividend Equity ETF808524797 | Reduced– | 7,67615,119 | −7,443−49.2% | $243.4K$463.9K | −$236.0K | 0.3%0.4% | −0.16 |
| REGNRegeneron Pharmaceuticals, Inc. | ReducedHistory | 415460 | −45−9.8% | $258.8K$355.0K | −$28.1K | 0.3%0.3% | −0.04 |
| LEGNLegend Biotech Corp | ReducedHistory | 10,56815,659 | −5,091−32.5% | $305.2K$283.3K | −$147.0K | 0.3%0.3% | +0.07 |
| WisdomTree Tr97717W562 | Reduced– | 7,0208,232 | −1,212−14.7% | $475.9K$477.9K | −$82.2K | 0.5%0.4% | +0.08 |
| EWEdwards Lifesciences Corp | ReducedHistory | 6,1586,574 | −416−6.3% | $557.1K$526.4K | −$37.6K | 0.6%0.5% | +0.13 |
| UNHUnitedHealth Group Inc | ReducedHistory | 1,4091,983 | −574−28.9% | $585.8K$536.6K | −$238.6K | 0.6%0.5% | +0.15 |
| iShares Inc46434G509 | Reduced– | 58,20358,540 | −337−0.6% | $2.60M$2.16M | −$15.1K | 2.8%2.0% | +0.86 |
| iShares Core S&P 500 ETF464287200 | Reduced– | 4,4504,474 | −24−0.5% | $3.33M$2.92M | −$18.0K | 3.6%2.7% | +0.96 |
| Flexshares Tr33939L688 | Reduced– | 21,66944,239 | −22,570−51.0% | $5.05M$8.84M | −$5.26M | 5.5%8.0% | −2.55 |
| DBX ETF Tr233051200 | Reduced– | 126,734126,892 | −158−0.1% | $6.92M$6.27M | −$8.63K | 7.5%5.7% | +1.82 |
| Nushares ETF Tr67092P300 | Reduced– | 140,912195,657 | −54,745−28.0% | $7.04M$8.90M | −$2.74M | 7.7%8.1% | −0.44 |
| iShares Inc46434G863 | Reduced– | 192,398369,453 | −177,055−47.9% | $10.5M$16.8M | −$9.68M | 11.4%15.3% | −3.84 |
| iShares Tr46435G516 | Reduced– | 104,247254,427 | −150,180−59.0% | $10.7M$24.3M | −$15.4M | 11.6%22.1% | −10.48 |
Estimated amounts multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares): new positions use this quarter's value and sold-out positions last quarter's; positions reported only as principal (PRN) cannot be estimated. 13F shows only quarter-end holdings, not when trades happened or at what price.